We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.1%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$84.4B
AUM Growth
+$1.88B
(+2.3%)
Cap. Flow
-$1.02B
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
26.68%
Holding
1,838
New
139
Increased
801
Reduced
650
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Imperial Bank of Commerce
CM
|
+$379M |
| 2 |
BGSI
Boyd Group Services
BGSI
|
+$328M |
| 3 |
B
Barrick Mining
B
|
+$295M |
| 4 |
Eli Lilly
LLY
|
+$220M |
| 5 |
Johnson & Johnson
JNJ
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$342M |
| 2 |
MRSH
Marsh
MRSH
|
+$266M |
| 3 |
Automatic Data Processing
ADP
|
+$234M |
| 4 |
Microsoft
MSFT
|
+$202M |
| 5 |
Sun Life Financial
SLF
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.65% |
| 2 | Technology | 21.47% |
| 3 | Industrials | 9.42% |
| 4 | Materials | 9.04% |
| 5 | Healthcare | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
V2X
VVX
$2.7B
| $1.01M | ﹤0.01% |
18,378
+3,569
| +24% | +$201K |
|
1052
DaVita
DVA
$15B
| $1.01M | ﹤0.01% |
8,914
-131
| -1% | -$15.9K |
|
1053
Rigel Pharmaceuticals
RIGL
$693M
| $1.01M | ﹤0.01% |
23,662
-5,630
| -19% | -$212K |
|
1054
GoodRx Holdings
GDRX
$1.07B
| $1.01M | ﹤0.01% |
+375,944
| New | +$1.23M |
|
1055
Appian
APPN
$2.03B
| $1.01M | ﹤0.01% |
28,222
-1,381
| -5% | -$49.2K |
|
1056
Alector
ALEC
$168M
| $1M | ﹤0.01% |
660,168
+376,456
| +133% | +$668K |
|
1057
Domino's
DPZ
$12.1B
| $1M | ﹤0.01% |
2,375
-1,377
| -37% | -$574K |
|
1058
Caledonia Mining Corp
CMCL
$363M
| $999K | ﹤0.01% |
37,431
+10,074
| +37% | +$296K |
|
1059
Spire
SR
$4.73B
| $987K | ﹤0.01% |
11,903
+8,231
| +224% | +$702K |
|
1060
LyondellBasell Industries
LYB
$19.6B
| $984K | ﹤0.01% |
22,586
-105,763
| -82% | -$4.79M |
|
1061
Landstar System
LSTR
$6B
| $983K | ﹤0.01% |
6,782
-416
| -6% | -$55.4K |
|
|
ALM
1062
Almonty Industries
ALM
$3.56B
| $982K | ﹤0.01% |
111,224
+41,331
| +59% | +$304K |
|
1063
Veracyte
VCYT
$3.58B
| $976K | ﹤0.01% |
23,137
-17,209
| -43% | -$694K |
|
1064
Carlyle Group
CG
$17.6B
| $973K | ﹤0.01% |
16,213
+953
| +6% | +$54.1K |
|
1065
Factset
FDS
$9.59B
| $970K | ﹤0.01% |
3,334
-1,165
| -26% | -$327K |
|
1066
Vanguard FTSE Europe ETF
VGK
$30.8B
| $969K | ﹤0.01% |
+11,560
| New | +$940K |
|
|
MRSN
1067
DELISTED
Mersana Therapeutics
MRSN
| $967K | ﹤0.01% |
33,834
-13,985
| -29% | -$266K |
|
1068
Puma Biotechnology
PBYI
$391M
| $966K | ﹤0.01% |
160,973
-14,237
| -8% | -$75.6K |
|
1069
Radian Group
RDN
$5.22B
| $965K | ﹤0.01% |
26,647
+16,871
| +173% | +$589K |
|
1070
Kratos Defense & Security Solutions
KTOS
$9.23B
| $958K | ﹤0.01% |
12,628
+1,091
| +9% | +$89.3K |
|
1071
Nextpower Inc
NXT
$13.8B
| $957K | ﹤0.01% |
11,015
+1,766
| +19% | +$160K |
|
1072
Gossamer Bio
GOSS
$84.9M
| $954K | ﹤0.01% |
306,453
-2,597
| -0.8% | -$7.41K |
|
1073
International Seaways
INSW
$4.71B
| $954K | ﹤0.01% |
19,760
+5,783
| +41% | +$286K |
|
1074
Scansource
SCSC
$1.16B
| $948K | ﹤0.01% |
24,013
-21,213
| -47% | -$876K |
|
1075
PVH
PVH
$4.09B
| $940K | ﹤0.01% |
13,831
-181
| -1% | -$14.2K |
|
Similar funds
Mackenzie Financial's Q4 2025 Portfolio in Review
As of Q4 2025, Mackenzie Financial held 1,838 positions worth $84.4B, up 2.3% from $82.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Mackenzie Financial's Q4 2025 filing shows 139 new, 801 increased, 650 reduced and 172 closed positions. Its largest new stake was Boyd Group Services: 2,050,220 shares worth $328M. The largest sale was Scotiabank, an estimated $342M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q4 2025 buy was Boyd Group Services: 2,050,220 shares worth $328M.
- Mackenzie Financial added most to Canadian Imperial Bank of Commerce in Q4 2025, an estimated $379M increase.
- Mackenzie Financial's biggest Q4 2025 reduction was Scotiabank, cutting an estimated $342M.
- Mackenzie Financial fully exited Novo Nordisk in Q4 2025, selling an estimated $16.1M.
- Mackenzie Financial's ten largest holdings make up 27% of its $84.4B portfolio in Q4 2025.
- Mackenzie Financial opened 139 new positions and closed 172 in Q4 2025.
- Mackenzie Financial's portfolio value rose 2.3% quarter-over-quarter to $84.4B.
Based on Mackenzie Financial's 13F filing for Q4 2025, filed 18 Feb 2026.